Latest Breaking News On - Sanofi ventures - Page 2 : comparemela.com

Mirador Therapeutics Raises Over 400M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Al iskandariyahSan diegoUnited statesMarkc mckennaFidelity management research companyMirador therapeutics incMirador therapeuticsFidelity managementResearch companyFarallon capital managementBoxer capitalLogos capitalMoore strategic venturesBlue owl healthcare opportunitiesSanofi venturesWoodline partners

Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million

Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Jodie morrisonPiper sandlerBrendan burnsSarah suttonOppenheimer coBio incBristol myers squibbHomology medicines incLatham watkinsAtlas ventureGoodwin procterOsage university partnersCu healthcare innovation fundAnnounces closingHomology medicinesConcurrent private placement

Sudo raises $147M to advance 2 TYK2 inhibitor therapies to trials

Sudo raises $147M to advance 2 TYK2 inhibitor therapies to trials
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Juergen eckhardtSudo biosciencesJonathan behrMatthias kleinzScott byrdDementia discovery fundSv health investors fundBayer agTranslational sciences investmentsEnavate sciencesRise fundSv health investorsFrazier life sciencesLife sciences innovationsSciences innovationsSanofi ventures

NextPoint Therapeutics Raises $42 5M; Closes $122 5M Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United kingdomR jacob vogelsteinArkin bioGordon freemanIvan cheungNextpoint therapeuticsCatalio capitalNextpoint boardSanofi venturesSixty degree capitalDana farber cancer instituteBinney street capitalArkin bio capital

Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round

The funding will advance two precision TYK2 inhibitors into the clinic for multiple sclerosis, psoriasis and other severe autoimmune and neurologic conditions.New investors include Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises.CARMEL, Ind. (BUSINESS WIRE) #TYK2 Sudo Biosciences (“Sudo”), a biophar.

City ofUnited kingdomUnited statesMatthias kleinzSudo bioscienceJuergen eckhardtScott byrdSudo biosciencesJonathan behrEli lillyBill gatesOtsuka astexFrazier life sciencesBayer agPlayers associationQuest diagnostics